In prostatic cancer (PC), TAGLN (tumor suppressor) and HLA had higher expression in the periphery, whereas NUPR1 and KLK4 etc. were expressed higher in the tumor core (82) (Figure 1C). This evidence concerns the gene KLK4 and neoplasm.